By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Allergan Inc. 

2525 Dupont Drive

Irvine  California  92612  U.S.A.
Phone: 714-246-4500 Fax: n/a


Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful treatments to help people reach their life’s potential. Today, we have approximately 11,100 highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than 100 countries, a rich and ever-evolving portfolio of pharmaceuticals, biologics, medical devices and over-the-counter consumer products, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly, move more freely and express themselves more fully. For the year ending 2012, our total product net sales totaled $5.5 billion, a 10 percent increase over 2011. From our beginnings as an eye care company to our focus today on several medical specialties, including eye care, neurosciences, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention and urologics, Allergan is proud to celebrate more than six decades of medical advances and proud to support the patients and physicians who rely on our products and the employees and communities in which we live and work. For more information regarding Allergan, go to:

Key Statistics

Ownership: Public

Web Site: Allergan
Employees: 11,100
Symbol: AGN



Elan Pharmaceuticals 

CeNes Pharmaceuticals (U.S.) 

PanVera LLC 

Pharmagene Laboratories Limited  Phase ZERO(TM) products and services.

Acadia  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

Acadia  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

Acadia  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.

Company News
Allergan (AGN) Anti-Infective Portfolio Highlighted In 13 Abstracts At IDWeek 2015 10/8/2015 7:00:35 AM
Allergan (AGN) And Medicines360 Announces LILETTA (levonorgestrel-Releasing Intrauterine System) 52 Mg IUS Presented In 3 Abstracts At FIGO 2015 10/6/2015 6:31:34 AM
Allergan (AGN) And Humana, Inc. (HUM) Announce Research Partnership To Improve Health Outcomes 10/2/2015 6:41:04 AM
Allergan (AGN) Successfully Completes Kythera (KYTH) Acquisition; Adds Game-Changing KYBELLA Treatment For Double-Chin 10/1/2015 7:45:18 AM
Allergan (AGN) Release: U.S. FDA Approves JUVEDERM ULTRA XC For Use In Lips 10/1/2015 6:04:41 AM
NuMedii, Inc. Announces Research Collaboration with Allergan (AGN) To Explore New Treatments For Psoriasis 9/29/2015 10:37:35 AM
Allergan (AGN) Announces Updated Second-Half 2015 Continuing Operations Financial Forecast 9/29/2015 7:34:13 AM
Allergan (AGN) Launches Generic Version Of INVEGA (paliperidone) 9/25/2015 12:00:34 PM
Amgen (AMGN) and Allergan (AGN)'s Avastin Copycat Succeeds in Late Stage Lung Cancer Study 9/23/2015 8:34:23 AM
Allergan (AGN) Supports World Alzheimer's Disease Day By Giving Back 9/22/2015 11:10:30 AM